These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 39289528)

  • 1. Autoantibodies in COVID-19 and Other Viral Diseases: Molecular, Cellular, and Clinical Perspectives.
    Chatterjee S; Bhattacharya M; Saxena S; Lee SS; Chakraborty C
    Rev Med Virol; 2024 Sep; 34(5):e2583. PubMed ID: 39289528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptive Immunity and the Risk of Autoreactivity in COVID-19.
    Moody R; Wilson K; Flanagan KL; Jaworowski A; Plebanski M
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unveiling the intricacies of COVID-19: Autoimmunity, multi-organ manifestations and the role of autoantibodies.
    Ding Z; Wei X; Pan H; Shi H; Shi Y
    Scand J Immunol; 2024 Feb; 99(2):e13344. PubMed ID: 39007954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 and autoimmune diseases.
    Liu Y; Sawalha AH; Lu Q
    Curr Opin Rheumatol; 2021 Mar; 33(2):155-162. PubMed ID: 33332890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune complications of COVID-19.
    Yazdanpanah N; Rezaei N
    J Med Virol; 2022 Jan; 94(1):54-62. PubMed ID: 34427929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies and autoimmune disorders in SARS-CoV-2 infection: pathogenicity and immune regulation.
    Darmarajan T; Paudel KR; Candasamy M; Chellian J; Madheswaran T; Sakthivel LP; Goh BH; Gupta PK; Jha NK; Devkota HP; Gupta G; Gulati M; Singh SK; Hansbro PM; Oliver BGG; Dua K; Chellappan DK
    Environ Sci Pollut Res Int; 2022 Aug; 29(36):54072-54087. PubMed ID: 35657545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 infection as a trigger of autoimmune response.
    Sacchi MC; Tamiazzo S; Stobbione P; Agatea L; De Gaspari P; Stecca A; Lauritano EC; Roveta A; Tozzoli R; Guaschino R; Bonometti R
    Clin Transl Sci; 2021 May; 14(3):898-907. PubMed ID: 33306235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2, the autoimmune virus.
    Halpert G; Shoenfeld Y
    Autoimmun Rev; 2020 Dec; 19(12):102695. PubMed ID: 33130000
    [No Abstract]   [Full Text] [Related]  

  • 9. Editorial: Autoantibodies to Components of the Immune System, Including Type 1 Interferons, and the Risk of Severe COVID-19.
    Parums DV
    Med Sci Monit; 2021 Sep; 27():e934766. PubMed ID: 34538868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New-onset IgG autoantibodies in hospitalized patients with COVID-19.
    Chang SE; Feng A; Meng W; Apostolidis SA; Mack E; Artandi M; Barman L; Bennett K; Chakraborty S; Chang I; Cheung P; Chinthrajah S; Dhingra S; Do E; Finck A; Gaano A; Geßner R; Giannini HM; Gonzalez J; Greib S; Gündisch M; Hsu AR; Kuo A; Manohar M; Mao R; Neeli I; Neubauer A; Oniyide O; Powell AE; Puri R; Renz H; Schapiro J; Weidenbacher PA; Wittman R; Ahuja N; Chung HR; Jagannathan P; James JA; Kim PS; Meyer NJ; Nadeau KC; Radic M; Robinson WH; Singh U; Wang TT; Wherry EJ; Skevaki C; Luning Prak ET; Utz PJ
    Nat Commun; 2021 Sep; 12(1):5417. PubMed ID: 34521836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune response after SARS-CoV-2 infection and SARS-CoV-2 vaccines.
    Hromić-Jahjefendić A; Lundstrom K; Adilović M; Aljabali AAA; Tambuwala MM; Serrano-Aroca Á; Uversky VN
    Autoimmun Rev; 2024 Mar; 23(3):103508. PubMed ID: 38160960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 and autoimmune diseases: is there a connection?
    Votto M; Castagnoli R; Marseglia GL; Licari A; Brambilla I
    Curr Opin Allergy Clin Immunol; 2023 Apr; 23(2):185-192. PubMed ID: 36728317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [SARS-CoV-2 infection and autoimmunity].
    Meyer-Bahlburg A
    Z Rheumatol; 2024 Feb; 83(1):34-40. PubMed ID: 38108865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Interferon Autoantibodies in Adult-Onset Immunodeficiency Syndrome and Severe COVID-19 Infection.
    Chen LF; Yang CD; Cheng XB
    Front Immunol; 2021; 12():788368. PubMed ID: 35003106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Earlier vs. later time period of COVID-19 infection and emergent autoimmune signs, symptoms, and serologies.
    Oakes EG; Dillon E; Buhler KA; Guan H; Paudel M; Marks K; Adejoorin I; Yee J; Ellrodt J; Tedeschi S; Sparks J; Case SM; Hsu T; Solomon DH; Jonsson AH; Alexander RV; Rao DA; Choi MY; Costenbader KH
    J Autoimmun; 2024 Sep; 148():103299. PubMed ID: 39096716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspectives on vaccine induced thrombotic thrombocytopenia.
    Dotan A; Shoenfeld Y
    J Autoimmun; 2021 Jul; 121():102663. PubMed ID: 34020254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 infection: a possible induction factor for development of autoimmune diseases?
    Saeedi N; Gohari NSF; Ghalibaf AAM; Dehghan A; Owlia MB
    Immunol Res; 2023 Aug; 71(4):547-553. PubMed ID: 37316687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 mRNA vaccine BNT162b2 induces autoantibodies against type I interferons in a healthy woman.
    Ning W; Xu W; Cong X; Fan H; Gilkeson G; Wu X; Hughes H; Jiang W
    J Autoimmun; 2022 Oct; 132():102896. PubMed ID: 36029717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development of anticyclic citrullinated peptide (anti-CCP) antibody following severe COVID-19.
    Roghani SA; Dastbaz M; Lotfi R; Shamsi A; Abdan Z; Rostampour R; Soleymani B; Zamanian MH; Soufivand P; Pournazari M; Taghadosi M
    Immun Inflamm Dis; 2024 May; 12(5):e1276. PubMed ID: 38780036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of autoantibodies in COVID-19 convalescents.
    Dobrowolska K; Zarębska-Michaluk D; Poniedziałek B; Jaroszewicz J; Flisiak R; Rzymski P
    J Med Virol; 2023 Jun; 95(6):e28864. PubMed ID: 37310140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.